Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation-Reference-Cited by-同舟云学术

Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation

Published:2014-11-24 Issue:49 Volume:111 Page:17582-17587
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Hefetz-Sela Simona,Stein Ilan,Klieger Yair,Porat Rinnat,Sade-Feldman Moshe,Zreik Farid,Nagler Arnon,Pappo Orit,Quagliata Luca,Dazert Eva,Eferl Robert,Terracciano Luigi,Wagner Erwin F.,Ben-Neriah Yinon,Baniyash Michal,Pikarsky Eli

Funder

EC | European Research Council (ERC)

Israel Science Foundation (ISF)

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference36 articles.

1. Trophic macrophages in development and disease

2. Macrophage plasticity and polarization: in vivo veritas

3. Cancer-related inflammation

4. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment

5. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products with anti-tumorigenesis potential targeting macrophage;Phytomedicine;2024-08

2. Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress;Frontiers in Pharmacology;2024-06-18

3. Insights into the crystal structure investigation and virtual screening approach of quinoxaline derivatives as potent against c-Jun N-terminal kinases 1;Journal of Biomolecular Structure and Dynamics;2024-02-07

4. The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook;Molecular Immunology;2022-11

5. Fragment-Based and Structural Investigation for Discovery of JNK3 Inhibitors;Pharmaceutics;2022-09-08